The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-Benzyl-(1-(4-(1-Naphthoyl)piperazin-1-yl)-6-acrylamido-1-oxohexan-2-yl)carbamate ID: ALA4093689
Chembl Id: CHEMBL4093689
PubChem CID: 132024475
Max Phase: Preclinical
Molecular Formula: C32H36N4O5
Molecular Weight: 556.66
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCN(C(=O)c2cccc3ccccc23)CC1
Standard InChI: InChI=1S/C32H36N4O5/c1-2-29(37)33-18-9-8-17-28(34-32(40)41-23-24-11-4-3-5-12-24)31(39)36-21-19-35(20-22-36)30(38)27-16-10-14-25-13-6-7-15-26(25)27/h2-7,10-16,28H,1,8-9,17-23H2,(H,33,37)(H,34,40)/t28-/m0/s1
Standard InChI Key: IQDAHYYYLIDXSI-NDEPHWFRSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 556.66Molecular Weight (Monoisotopic): 556.2686AlogP: 3.89#Rotatable Bonds: 11Polar Surface Area: 108.05Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.49CX Basic pKa: ┄CX LogP: 3.59CX LogD: 3.59Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.28Np Likeness Score: -0.70
References 1. Akbar A, McNeil NMR, Albert MR, Ta V, Adhikary G, Bourgeois K, Eckert RL, Keillor JW.. (2017) Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase., 60 (18): [PMID:28858494 ] [10.1021/acs.jmedchem.7b01070 ] 2. McNeil NMR, Gates EWJ, Firoozi N, Cundy NJ, Leccese J, Eisinga S, Tyndall JDA, Adhikary G, Eckert RL, Keillor JW.. (2022) Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors., 232 [PMID:35158154 ] [10.1016/j.ejmech.2022.114172 ] 3. Cundy NJ, Arciszewski J, Gates EWJ, Acton SL, Passley KD, Awoonor-Williams E, Boyd EK, Xu N, Pierson É, Fernandez-Ansieta C, Albert MR, McNeil NMR, Adhikary G, Eckert RL, Keillor JW.. (2023) Novel irreversible peptidic inhibitors of transglutaminase 2., 14 (2.0): [PMID:36846375 ] [10.1039/d2md00417h ]